[[Glioma]]s, especially **[[glioblastoma]] (GBM)**, express **[[tumor-specific antigen]]s (TSAs)** and **[[tumor-associated antigen]]s (TAAs)** that can be targeted by [[vaccine]]s. The goal is to trigger a **[[T cell–mediated immune response]]** against [[tumor cell]]s without harming healthy [[brain tissue]].